Lloyd Mitchell Segal - 18 May 2021 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role
President and CEO
Signature
/s/ Steve Forte, Attorney-in-Fact
Issuer symbol
RPTX
Transactions as of
18 May 2021
Net transactions value
-$196,228
Form type
4
Filing time
20 May 2021, 18:19:00 UTC
Next filing
21 May 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPTX Common Stock Sale $63,000 -1,800 -1.3% $35.00 141,154 18 May 2021 See Footnote F1, F2
transaction RPTX Common Stock Sale $133,228 -3,800 -2.7% $35.06 137,354 19 May 2021 See Footnote F1, F2, F3
holding RPTX Common Stock 5,000 18 May 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 31, 2020.
F2 These securities are registered in the name of Arvala Inc. (f/k/a 3996953 Canada Inc., the "Company"). The Reporting Person is the sole stockholder of the Company.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.25, inclusive.